MYH9 and nasopharyngeal carcinoma: In nasopharyngeal carcinoma, CB-induced ENKUR similarly inhibited β-catenin/c-Jun/MYH9 signaling, reducing UBE3A-mediated p53 ubiquitination and degradation (Hou et al., 2022b).